These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9482404)

  • 1. Current status of solvent/detergent-treated frozen plasma.
    Klein HG; Dodd RY; Dzik WH; Luban NL; Ness PM; Pisciotto P; Schiff PD; Snyder EL
    Transfusion; 1998 Jan; 38(1):102-7. PubMed ID: 9482404
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 3. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of solvent/detergent-treated plasma in patients with a prolonged prothrombin time.
    Lerner RG; Nelson J; Sorcia E; Grima K; Kancherla RR; Zarou-Naimo CM; Pehta JC
    Vox Sang; 2000; 79(3):161-7. PubMed ID: 11111235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate.
    Roberts PL; Dunkerley C
    Vox Sang; 2003 Apr; 84(3):170-5. PubMed ID: 12670365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral safety of hemoderivatives: in search of zero risk].
    Hernández JM; Tusell JM
    Sangre (Barc); 1996 Apr; 41(2):97-100. PubMed ID: 9045365
    [No Abstract]   [Full Text] [Related]  

  • 8. Virally inactivated fresh frozen plasma.
    Williamson LM; Allain JP
    Vox Sang; 1995; 69(3):159-65. PubMed ID: 8578727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral safety of solvent-detergent treated blood products.
    Horowitz B; Prince AM; Horowitz MS; Watklevicz C
    Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
    Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
    Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas).
    Magner JJ; Crowley KJ; Boylan JF
    J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):410-3. PubMed ID: 17544896
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of solvent/detergent-treated plasma on stored platelet concentrates.
    Tocci LJ; Napychank PA; Cable RG; Snyder EL
    Transfusion; 1993 Feb; 33(2):145-9. PubMed ID: 8430454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent/detergent-treated plasma: a tale of 30 years of experience.
    Liumbruno GM; Marano G; Grazzini G; Capuzzo E; Franchini M
    Expert Rev Hematol; 2015 Jun; 8(3):367-74. PubMed ID: 25695198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin.
    Uemura Y; Yang YH; Heldebrant CM; Takechi K; Yokoyama K
    Vox Sang; 1994; 67(3):246-54. PubMed ID: 7863623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fresh frozen plasma: is it farewell?
    Cash J
    Vox Sang; 1994; 67 Suppl 3():121-4. PubMed ID: 7975473
    [No Abstract]   [Full Text] [Related]  

  • 16. Virus safety of pooled fresh-frozen plasma inactivated by solvent/detergent treatment.
    Prince AM; Horowitz B
    Beitr Infusionsther; 1993; 31():21-4. PubMed ID: 7693256
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma.
    Horowitz B; Lazo A; Grossberg H; Page G; Lippin A; Swan G
    Vox Sang; 1998; 74 Suppl 1():203-6. PubMed ID: 9789529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma.
    Rock G; Yousef H; Neurath D; Lu M
    Transfus Apher Sci; 2006 Dec; 35(3):235-8. PubMed ID: 17112784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.
    Biesert L; Suhartono H
    Vox Sang; 1998; 74 Suppl 1():207-12. PubMed ID: 9789530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).
    de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
    Anesth Analg; 2002 May; 94(5):1127-31, table of contents. PubMed ID: 11973173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.